- Home
- SIDU vs ANTX Comparison
SIDU vs ANTX Comparison
Compare SIDU & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIDU
- ANTX
- Stock Information
- Founded
- SIDU 2012
- ANTX 2017
- Country
- SIDU United States
- ANTX United States
- Employees
- SIDU N/A
- ANTX N/A
- Industry
- SIDU Telecommunications Equipment
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- SIDU Telecommunications
- ANTX Health Care
- Exchange
- SIDU Nasdaq
- ANTX Nasdaq
- Market Cap
- SIDU 30.0M
- ANTX 33.2M
- IPO Year
- SIDU 2021
- ANTX 2022
- Fundamental
- Price
- SIDU $1.15
- ANTX $1.07
- Analyst Decision
- SIDU
- ANTX Buy
- Analyst Count
- SIDU 0
- ANTX 2
- Target Price
- SIDU N/A
- ANTX $2.00
- AVG Volume (30 Days)
- SIDU 1.6M
- ANTX 71.9K
- Earning Date
- SIDU 08-18-2025
- ANTX 08-12-2025
- Dividend Yield
- SIDU N/A
- ANTX N/A
- EPS Growth
- SIDU N/A
- ANTX N/A
- EPS
- SIDU N/A
- ANTX N/A
- Revenue
- SIDU $3,860,985.00
- ANTX N/A
- Revenue This Year
- SIDU $144.49
- ANTX N/A
- Revenue Next Year
- SIDU N/A
- ANTX N/A
- P/E Ratio
- SIDU N/A
- ANTX N/A
- Revenue Growth
- SIDU N/A
- ANTX N/A
- 52 Week Low
- SIDU $1.08
- ANTX $0.87
- 52 Week High
- SIDU $7.65
- ANTX $2.73
- Technical
- Relative Strength Index (RSI)
- SIDU 31.00
- ANTX 45.56
- Support Level
- SIDU $1.08
- ANTX $1.05
- Resistance Level
- SIDU $2.19
- ANTX $1.16
- Average True Range (ATR)
- SIDU 0.13
- ANTX 0.03
- MACD
- SIDU -0.10
- ANTX 0.00
- Stochastic Oscillator
- SIDU 6.31
- ANTX 18.87
About SIDU Sidus Space Inc.
Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.